Human Insulin
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79720R0010
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice is seeking proposals for a requirements contract to supply various types of human insulin to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The VA intends to award one contract per product group or a combined contract. Offerors must identify by exact name and NDC number the insulin products to be supplied. The solicitation will be issued on January 3, 2020 with responses due January 17, 2020. The contract would have a one year base period and four one-year option periods. Evaluation will consider an offeror's ability to provide an uninterrupted supply of the contracted insulin items.
There is no set-aside designated for this procurement. The NAICS code is 325412 for Pharmaceutical Preparation Manufacturing. The estimated total annual insulin requirements across the two product groups are over 5 million units, including various insulin types in vial and pen packaging configurations. Interested parties should monitor the listed website for solicitation updates and amendments leading up to the anticipated January 3rd issuance date. Stevan Vasich is the point of contact for any questions.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0010 for an unrestrictive procurement for Human Insulins, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will make one award for each individual product group (group 1 and 2) or a combination of products groups to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about January 3rd, 2020, with a tentative closing date of January 17th, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download on Contract Opportunities at the following URL: https://beta.sam.gov/search?index=opp. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Stevan Vasich. Questions can be e-mailed to: Stevan.Vasich@va.gov.
The estimated annual requirements are as follows:
Group 1
Line Item
Description
Package Size
Total Estimated Annual Usage
1
Human R
10 ML Vial
401,899
2
Human N
10 ML Vial
797,954
3
Human 70/30
10 ML Vial
786,765
4
Short Acting/Intermediate Analog Mix Human (75/25 Mix or 70/30 Mix)
10 ML Vial
1632,521
5
Short Acting/Intermediate Analog Mix Human (75/25 Mix or 70/30 Mix)
5X3 ML Disposable Pen
235,244
Group 2
Line Item
Description
Package Size
Total Estimated Annual Usage
1
Short Acting Analog Human
5X3 ML Disposable Pen
1,180,380
2
Short Acting Analog Human
10 ML Vial
1,287,581
Files
| File | Type | Posted |
|---|---|---|
| 36E79720R0010-000.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Human Insulin Effective 7/1/2020 - 6/30/2021 | Award Notice | |
| Human Insulin (Amendment to add NDC and NDA/ANDA Number Entries on the Continuation of Standard Form 1449) | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--Ramipril Capsules RFP | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity